Loading clinical trials...

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department | Clinical Trials | Clareo Health

RECRUITINGPHASE3

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Intravenous Magnesium Sulfate Vs Placebo to Treat Non-traumatic Acute Headaches in the Emergency Department

NCT05325580•University of Monastir

View on ClinicalTrials.gov

Summary

Detailed Description

Rate of Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Eligibility

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•informed consent
•age \>18 years
•Acute non-traumatic acute headaches
•patients treated in ED
•Magnesium sulfate and aspirin administered intravenously (IV)

Exclusion Criteria

•Current regular use of analgesics, anticonvulsants or antidepressants
•Renal disorder with a low glomerular filtration rate (\<60 ml/min)
•Neuromuscular disorder
•Pregnant woman
•Contrindication
•Allergy to NSAID
•Traumatic Headache
•Chronic headache ( headache occurring at least 15 days per month for at least 3 months)
•Hemodynamic instability

Locations (1)

University of Monasrtir

Monastir, Tunisia

Key Dates

Start Date

December 1, 2021

Primary Completion Date

December 1, 2025

Completion Date

December 30, 2026

Last Updated

February 28, 2024

Enrollment

424

ESTIMATED participants

Conditions

Head Pain

Interventions

Magnesium sulfate

DRUG

Contacts

Semir Nouira, Professor

CONTACT

7310600 semir.nouira@rns.tn

Khaoula Bel Haj Ali, MD

CONTACT

7310600 belhajalikhaoula@yahoo.fr

Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries

NCT07155109

Intracranial Pressure IncreaseAbdominal Pain+1 more

View study

COMPLETED

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

NCT04138316

MigraineHead Pain

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Inclusion Criteria

Exclusion Criteria

Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

Effect of Exercises on Computer Vision Syndrome

Copeptin for Risk Stratification in Non-traumatic Headache in the Emergency Setting - The CoHead Study